Limitations of the ACS NSQIP in Thyroid Surgery Rebecca S. SippelHerbert Chen Endocrine Tumors 14 July 2011 Pages: 3529 - 3530
Melanoma in the Older Patient: Measuring Frailty as an Index of Survival Julie R. LangeSewon KangCharles M. Balch Melanomas 31 August 2011 Pages: 3531 - 3532
Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer: The Future Ain’t What It Used To Be Peter J. Allen Pancreatic Tumors 27 September 2011 Pages: 3533 - 3534
Quality Improvement in Multidisciplinary Cancer Teams: An Investigation of Teamwork and Clinical Decision-Making and Cross-Validation of Assessments B. W. LambN. SevdalisJ. S. A. Green Healthcare Policy and Outcomes 19 May 2011 Pages: 3535 - 3543
Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group Kathleen M. DiehlErin M. GreenLisa A. Newman Healthcare Policy and Outcomes 17 June 2011 Pages: 3544 - 3550
Medical and Surgical Risks in Thyroid Surgery: Lessons from the NSQIP Melanie GoldfarbZvi PerrySareh Parangi Endocrine Tumors 20 July 2011 Pages: 3551 - 3558
Risk Factors for Nonsynchronous Second Primary Malignancy and Related Death in Patients with Differentiated Thyroid Carcinoma Brian Hung-Hin LangKai Pun Wong Endocrine Tumors Open access 15 May 2011 Pages: 3559 - 3565
Both BRAF V600E Mutation and Older Age (≥65 Years) are Associated with Recurrent Papillary Thyroid Cancer Gina M. HowellSally E. CartyLinwah Yip Endocrine Tumors 19 May 2011 Pages: 3566 - 3571
Staging of Papillary Thyroid Carcinoma with Ultrasonography: Performance in a Large Series Ji Soo ChoiWoong Youn ChungEun-Kyung Kim Endocrine Tumors 19 May 2011 Pages: 3572 - 3578
Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma Michael S. SabelJay LeeStewart Wang Melanomas 06 August 2011 Pages: 3579 - 3585
Outcome After Therapeutic Lymph Node Dissection in Patients with Unknown Primary Melanoma Site Sebastiaan P. PrensAugustinus P. T. van der PloegCornelis Verhoef Melanomas Open access 25 May 2011 Pages: 3586 - 3592
Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database Richard L. White Jr.Gregory D. Ayersfor the Sentinel Lymph Node Working Group Melanomas 07 June 2011 Pages: 3593 - 3600
Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer Yun Shin ChunHarry S. CooperJohn P. Hoffman Pancreatic Tumors 27 September 2011 Pages: 3601 - 3607
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection Stefano PartelliStefano CrippaMassimo Falconi Pancreatic Tumors 17 May 2011 Pages: 3608 - 3614
Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial Matthew H. G. KatzRobert WolffPeter W. T. Pisters Pancreatic Tumors 24 June 2011 Pages: 3615 - 3622
Robot-Assisted Spleen-Preserving Laparoscopic Distal Pancreatectomy Sung Hoon ChoiChang Moo KangHoon Sang Chi Original Article - Pancreatic Tumors 12 June 2011 Pages: 3623 - 3623
Adjuvant Chemolipiodolization Reduces Early Recurrence Derived from Intrahepatic Metastasis of Hepatocellular Carcinoma After Hepatectomy Masaki UenoKazuhisa UchiyamaHiroki Yamaue Hepatobiliary Tumors 26 May 2011 Pages: 3624 - 3631
Locoregional Therapy-Induced Tumor Necrosis as a Predictor of Recurrence after Liver Transplant in Patients with Hepatocellular Carcinoma Meng-Hsing HoChih-Yung YuChung-Bao Hsieh Hepatobiliary Tumors 28 May 2011 Pages: 3632 - 3639
The Predictive Value of Postoperative Clinical Risk Scores for Outcome After Hepatic Resection: A Validation Analysis in 807 Patients Nuh N. RahbariChristoph ReissfelderJürgen Weitz Hepatobiliary Tumors 15 June 2011 Pages: 3640 - 3649
Efficacy of Surgical Microwave Therapy in Patients with Unresectable Hepatocellular Carcinoma Shinji ItohYasuharu IkedaKenji Takenaka Hepatobiliary Tumors 15 June 2011 Pages: 3650 - 3656
Surgery Versus Intra-arterial Therapy for Neuroendocrine Liver Metastasis: A Multicenter International Analysis Skye C. MayoMechteld C. de JongTimothy M. Pawlik Hepatobiliary Tumors 17 June 2011 Pages: 3657 - 3665
Recurrence Rates and Prognostic Factors in ypN0 Rectal Cancer After Neoadjuvant Chemoradiation and Total Mesorectal Excision Anand GovindarajanDiane ReidyGarrett M. Nash Colorectal Cancer 18 May 2011 Pages: 3666 - 3672
Survival and Quality of Life Following Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colonic Origin Adrienne R. HillRichard P. McQuellonEdward A. Levine Colorectal Cancer 15 June 2011 Pages: 3673 - 3679
The Revised ACPGBI Model is a Simple and Accurate Predictor of Operative Mortality After Potentially Curative Resection of Colorectal Cancer Colin H. RichardsE. Fiona LeitchPaul G. Horgan Colorectal Cancer 15 June 2011 Pages: 3680 - 3685
Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies Claudio BellucoAntonino De PaoliFrancesco De Marchi Colorectal Cancer Open access 21 June 2011 Pages: 3686 - 3693
Molecular Profiling of Colon Tumors: The Search for Clinically Relevant Biomarkers of Progression, Prognosis, Therapeutics, and Predisposition Manny D. BacolodFrancis Barany Colorectal Cancer 24 February 2011 Pages: 3694 - 3700
Laparoscopy-Assisted Distal Gastrectomy for Early Gastric Cancer: A Video Demonstration Seigo KitanoTsuyoshi EtohNorio Shiraishi Gastrointestinal Oncology 02 July 2011 Pages: 3701 - 3701
Viable Tumor Tissue Adherent to Needle Applicators after Local Ablation: A Risk Factor for Local Tumor Progression Nikol SnoerenJoost HuiskensThomas M. van Gulik Gastrointestinal Oncology Open access 18 May 2011 Pages: 3702 - 3710
Oral Vitamin B12 Replacement: An Effective Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients Hyoung-Il KimWoo Jin HyungSung Hoon Noh Gastrointestinal Oncology 10 May 2011 Pages: 3711 - 3717
Borrmann’s Macroscopic Criteria and p-Smad2 Expression Are Useful Predictive Prognostic Markers for Cytology-Positive Gastric Cancer Patients Without Overt Peritoneal Metastasis Satoru NodaMasakazu YashiroKosei Hirakawa Gastrointestinal Oncology 15 May 2011 Pages: 3718 - 3725
Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer Patients with Peritoneal Dissemination Yoshiyuki FujiwaraShuji TakiguchiYuichiro Doki Gastrointestinal Oncology 17 May 2011 Pages: 3726 - 3731
Safety of Thoracoscopic Lobectomy in Locally Advanced Lung Cancer Mark HennonRohit K. SahaiChukwumere Nwogu Thoracic Oncology 12 July 2011 Pages: 3732 - 3736
Modified Pleural Tenting for Prevention of Anastomotic Leak After Ivor Lewis Esophagogastrectomy Christos AsteriouNikolaos BarbetakisChristodoulos Tsilikas Thoracic Oncology 15 June 2011 Pages: 3737 - 3742
Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution Carlo CastoroMarco ScarpaErmanno Ancona Gastrointestinal Oncology 10 May 2011 Pages: 3743 - 3754
Oncologic Impact of the Curettage of Grade 2 Central Chondrosarcoma of the Extremity Wan Hyeong ChoWon Seok SongSoo-Yong Lee Bone and Soft Tissue Sarcomas 25 May 2011 Pages: 3755 - 3761
Diagnosis, Management, and Outcome of Patients with Dedifferentiated Liposarcoma Systemic Metastasis Markus P. GhadimiTariq Al-ZaidDina Lev Bone and Soft Tissue Sarcomas 26 May 2011 Pages: 3762 - 3770
Sarcoma Lung Metastases Treated with Percutaneous Radiofrequency Ablation: Results from 29 Patients J. PalussièreA. ItalianoB. N. Bui Bone and Soft Tissue Sarcomas 03 June 2011 Pages: 3771 - 3777
Outcomes of Screening-Detected Ductal Carcinoma In Situ Treated with Wide Excision Alone Jonathan FongEmil D. KurniawanG. Bruce Mann Breast Oncology 01 June 2011 Pages: 3778 - 3784
Office Ductoscopy for Surgical Selection in Women with Pathologic Nipple Discharge Seema A. KhanAmrit MangatNora Hansen Breast Oncology 28 May 2011 Pages: 3785 - 3790
Sentinel Lymph Node Pressure in Breast Cancer S. David NathansonMeredith Mahan Breast Oncology 28 May 2011 Pages: 3791 - 3796
The Safety of Multiple Re-excisions after Lumpectomy for Breast Cancer Suzanne CoopeyBarbara L. SmithMichelle C. Specht Breast Oncology 01 June 2011 Pages: 3797 - 3801
Needle Versus Excisional Biopsy for Noninvasive and Invasive Breast Cancer: Report from the National Cancer Data Base, 2003–2008 Richelle T. WilliamsKatharine YaoDavid P. Winchester Breast Oncology 01 June 2011 Pages: 3802 - 3810
Prognostic Value of Pathological Resection Margin Distance in Squamous Cell Cancer of the Vulva Linn WoelberMatthias ChoschzickSven Mahner Gynecologic Oncology 19 May 2011 Pages: 3811 - 3818
Risk and Predictors of Malignancy in Women with Endometrial Polyps Stephanie L. WethingtonThomas J. HerzogJason D. Wright Gynecologic Oncology 24 June 2011 Pages: 3819 - 3823
Is Neo-adjuvant Chemotherapy a “Waiver” of Extensive Upper Abdominal Surgery in Advanced Epithelial Ovarian Cancer? Sokbom KangYoo Heon JongSang-Yoon Park Gynecologic Oncology 21 June 2011 Pages: 3824 - 3827
Significance of Perineural Invasion, Lymphovascular Invasion, and High-Grade Prostatic Intraepithelial Neoplasia in Robot-Assisted Laparoscopic Radical Prostatectomy Jae Hung JungJae Won LeeKoon Ho Rha Urologic Oncology 10 June 2011 Pages: 3828 - 3832
Oncologic Outcomes and Survival in pT0 Tumors After Radical Cystectomy in Patients Without Neoadjuvant Chemotherapy: Results from a Large Multicentre Collaborative Study Morgan RouprêtSarah J. Drouinfor the Bladder Cancer Committee of the French National Association of Urology (“CC-AFU Vessie”) Urologic Oncology 07 June 2011 Pages: 3833 - 3838
Basal-Like Breast Cancer Defined by FOXC1 Expression Offers Superior Prognostic Value: A Retrospective Immunohistochemical Study Partha S. RaySanjay P. BagariaArmando E. Giuliano Translational Research and Biomarkers 18 March 2011 Pages: 3839 - 3847
Suppression of T-Cell Expansion by Melanoma is Exerted on Resting Cells Andrew J. RussLucy WentworthClifford S. Cho Translational Research and Biomarkers 05 April 2011 Pages: 3848 - 3857
Decreased Expression of RASSF6 Is a Novel Independent Prognostic Marker of a Worse Outcome in Gastric Cancer Patients after Curative Surgery Yugang WenQuan WangZhihai Peng Translational Research and Biomarkers 26 March 2011 Pages: 3858 - 3867
